These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 14688091)

  • 21.
    Colombo AC; Rella A; Normile T; Joffe LS; Tavares PM; de S Araújo GR; Frases S; Orner EP; Farnoud AM; Fries BC; Sheridan B; Nimrichter L; Rodrigues ML; Del Poeta M
    mBio; 2019 Apr; 10(2):. PubMed ID: 30940711
    [No Abstract]   [Full Text] [Related]  

  • 22. Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy.
    da Silva TA; Hauser PJ; Bandey I; Laskowski T; Wang Q; Najjar AM; Kumaresan PR
    Cytotherapy; 2021 Feb; 23(2):119-130. PubMed ID: 33303326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulated Release of Cryptococcal Polysaccharide Drives Virulence and Suppresses Immune Cell Infiltration into the Central Nervous System.
    Denham ST; Verma S; Reynolds RC; Worne CL; Daugherty JM; Lane TE; Brown JCS
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29203547
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunomodulatory Role of Capsular Polysaccharides Constituents of
    Decote-Ricardo D; LaRocque-de-Freitas IF; Rocha JDB; Nascimento DO; Nunes MP; Morrot A; Freire-de-Lima L; Previato JO; Mendonça-Previato L; Freire-de-Lima CG
    Front Med (Lausanne); 2019; 6():129. PubMed ID: 31275938
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Gonçalves DS; Rodriguez de La Noval C; Ferreira MDS; Honorato L; Araújo GRS; Frases S; Pizzini CV; Nosanchuk JD; Cordero RJB; Rodrigues ML; Peralta JM; Nimrichter L; Guimarães AJ
    Front Cell Infect Microbiol; 2020; 10():565571. PubMed ID: 33585262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of the wheat germ lectin to Cryptococcus neoformans chitooligomers affects multiple mechanisms required for fungal pathogenesis.
    Fonseca FL; Guimarães AJ; Kmetzsch L; Dutra FF; Silva FD; Taborda CP; Araujo Gde S; Frases S; Staats CC; Bozza MT; Schrank A; Vainstein MH; Nimrichter L; Casadevall A; Rodrigues ML
    Fungal Genet Biol; 2013 Nov; 60():64-73. PubMed ID: 23608320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells.
    Chaka W; Verheul AF; Vaishnav VV; Cherniak R; Scharringa J; Verhoef J; Snippe H; Hoepelman IM
    Infect Immun; 1997 Jan; 65(1):272-8. PubMed ID: 8975923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary surfactant protein A binds to Cryptococcus neoformans without promoting phagocytosis.
    Walenkamp AM; Verheul AF; Scharringa J; Hoepelman IM
    Eur J Clin Invest; 1999 Jan; 29(1):83-92. PubMed ID: 10092994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan.
    Rodrigues ML; Alvarez M; Fonseca FL; Casadevall A
    Eukaryot Cell; 2008 Apr; 7(4):602-9. PubMed ID: 18039942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucuronoxylomannan-mediated interaction of Cryptococcus neoformans with human alveolar cells results in fungal internalization and host cell damage.
    Barbosa FM; Fonseca FL; Holandino C; Alviano CS; Nimrichter L; Rodrigues ML
    Microbes Infect; 2006 Feb; 8(2):493-502. PubMed ID: 16293436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parallel beta-helix proteins required for accurate capsule polysaccharide synthesis and virulence in the yeast Cryptococcus neoformans.
    Liu OW; Kelly MJ; Chow ED; Madhani HD
    Eukaryot Cell; 2007 Apr; 6(4):630-40. PubMed ID: 17337638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The polysaccharide capsule of Cryptococcus neoformans interferes with human dendritic cell maturation and activation.
    Vecchiarelli A; Pietrella D; Lupo P; Bistoni F; McFadden DC; Casadevall A
    J Leukoc Biol; 2003 Sep; 74(3):370-8. PubMed ID: 12949240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The physical properties of the capsular polysaccharides from Cryptococcus neoformans suggest features for capsule construction.
    McFadden DC; De Jesus M; Casadevall A
    J Biol Chem; 2006 Jan; 281(4):1868-75. PubMed ID: 16278213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan.
    Yauch LE; Lam JS; Levitz SM
    PLoS Pathog; 2006 Nov; 2(11):e120. PubMed ID: 17096589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsule.
    Ibrahim AS; Filler SG; Alcouloumre MS; Kozel TR; Edwards JE; Ghannoum MA
    Infect Immun; 1995 Nov; 63(11):4368-74. PubMed ID: 7591072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans.
    Monari C; Kozel TR; Bistoni F; Vecchiarelli A
    Infect Immun; 2002 Jul; 70(7):3363-70. PubMed ID: 12065474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoregulation by capsular components of Cryptococcus neoformans.
    Vecchiarelli A
    Med Mycol; 2000 Dec; 38(6):407-17. PubMed ID: 11204878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cryptococcus neoformans glucuronoxylomannan fractions of different molecular masses are functionally distinct.
    Albuquerque PC; Fonseca FL; Dutra FF; Bozza MT; Frases S; Casadevall A; Rodrigues ML
    Future Microbiol; 2014; 9(2):147-61. PubMed ID: 24571070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of the mannan backbone of cryptococcal glucuronoxylomannan and a glycolytic enzyme of Staphylococcus aureus to contact-mediated killing of Cryptococcus neoformans.
    Ikeda R; Saito F; Matsuo M; Kurokawa K; Sekimizu K; Yamaguchi M; Kawamoto S
    J Bacteriol; 2007 Jul; 189(13):4815-26. PubMed ID: 17483230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils.
    Monari C; Retini C; Casadevall A; Netski D; Bistoni F; Kozel TR; Vecchiarelli A
    Eur J Immunol; 2003 Apr; 33(4):1041-51. PubMed ID: 12672070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.